Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01888822Phase 4Terminated
Phase 4, randomised trial in cholelithiasis comparing Placebo, Ampicillin-sulbactam and Ciprofloxacin (3 arms). Primary endpoint: Surgical site infection at 30 days. Started Jun 2013; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01888822.